{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36795846",
  "DateCompleted": {
    "Year": "2023",
    "Month": "02",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "02",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "02",
        "Day": "16"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1161/CIRCRESAHA.122.321670"
    ],
    "Journal": {
      "ISSN": "1524-4571",
      "JournalIssue": {
        "Volume": "132",
        "Issue": "4",
        "PubDate": {
          "Year": "2023",
          "Month": "Feb",
          "Day": "17"
        }
      },
      "Title": "Circulation research",
      "ISOAbbreviation": "Circ Res"
    },
    "ArticleTitle": "Modeling Heart Diseases on a Chip: Advantages and Future Opportunities.",
    "Pagination": {
      "StartPage": "483",
      "EndPage": "497",
      "MedlinePgn": "483-497"
    },
    "Abstract": {
      "AbstractText": [
        "Heart disease is a significant burden on global health care systems and is a leading cause of death each year. To improve our understanding of heart disease, high quality disease models are needed. These will facilitate the discovery and development of new treatments for heart disease. Traditionally, researchers have relied on 2D monolayer systems or animal models of heart disease to elucidate pathophysiology and drug responses. Heart-on-a-chip (HOC) technology is an emerging field where cardiomyocytes among other cell types in the heart can be used to generate functional, beating cardiac microtissues that recapitulate many features of the human heart. HOC models are showing great promise as disease modeling platforms and are poised to serve as important tools in the drug development pipeline. By leveraging advances in human pluripotent stem cell-derived cardiomyocyte biology and microfabrication technology, diseased HOCs are highly tuneable and can be generated via different approaches such as: using cells with defined genetic backgrounds (patient-derived cells), adding small molecules, modifying the cells' environment, altering cell ratio/composition of microtissues, among others. HOCs have been used to faithfully model aspects of arrhythmia, fibrosis, infection, cardiomyopathies, and ischemia, to name a few. In this review, we highlight recent advances in disease modeling using HOC systems, describing instances where these models outperformed other models in terms of reproducing disease phenotypes and/or led to drug development."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Toronto General Hospital Research Institute (O.M., R.Y., M.L., S.S.N.), University Health Network, Toronto, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute of Biomedical Engineering (O.M., R.Y., M.L., S.S.N.), University of Toronto, Canada."
          }
        ],
        "LastName": "Mourad",
        "ForeName": "Omar",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Toronto General Hospital Research Institute (O.M., R.Y., M.L., S.S.N.), University Health Network, Toronto, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute of Biomedical Engineering (O.M., R.Y., M.L., S.S.N.), University of Toronto, Canada."
          }
        ],
        "LastName": "Yee",
        "ForeName": "Ryan",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Toronto General Hospital Research Institute (O.M., R.Y., M.L., S.S.N.), University Health Network, Toronto, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute of Biomedical Engineering (O.M., R.Y., M.L., S.S.N.), University of Toronto, Canada."
          }
        ],
        "LastName": "Li",
        "ForeName": "Mengyuan",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0003-0906-7204"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Toronto General Hospital Research Institute (O.M., R.Y., M.L., S.S.N.), University Health Network, Toronto, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Ajmera Transplant Center (S.S.N.), University Health Network, Toronto, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute of Biomedical Engineering (O.M., R.Y., M.L., S.S.N.), University of Toronto, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine and Pathobiology (S.S.N.), University of Toronto, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Heart and Stroke/Richard Lewar Centre of Excellence (S.S.N.), University of Toronto, Canada."
          }
        ],
        "LastName": "Nunes",
        "ForeName": "Sara S",
        "Initials": "SS"
      }
    ],
    "GrantList": [
      {
        "GrantID": "PJT153160",
        "Agency": "CIHR",
        "Country": "Canada"
      },
      {
        "GrantID": "PJT180641",
        "Agency": "CIHR",
        "Country": "Canada"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Circ Res",
    "NlmUniqueID": "0047103",
    "ISSNLinking": "0009-7330"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "Circ Res. 2023 Feb 17;132(4):481-482",
      "PMID": "36795848"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapy",
        "metabolism"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Myocytes, Cardiac"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Cardiomyopathies"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Pluripotent Stem Cells"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lab-On-A-Chip Devices"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Induced Pluripotent Stem Cells"
    }
  ]
}